In both comparison groups (healthy/positive and positive/recovered), we found that activated CD4+ T and CD8+ T cell populations (CD8+ TCM and CD8+ TEM) majorly expressed enriched pathways in the COVID-19 patients (Figures 4C,D). The gene discussed is CD4; the disease is COVID-19.